Press release
Dr. Jeff Geschwind to Present at the Prestigious Veith Symposium 2025 in New York City
For more than four decades, the Veith Symposium has provided leading physicians, surgeons, and researchers from around the world a forum to exchange knowledge, discuss emerging technologies, and debate pressing clinical challenges in vascular medicine. This year's event will be held from November 18-22, 2025, at the New York Hilton Midtown, and is expected to feature over 1,300 fast-paced presentations covering cutting-edge topics in vascular, endovascular, and oncologic care.
Dr. Geschwind's participation highlights his continued dedication to advancing interventional oncology-a field he helped pioneer and shape into one of the most dynamic areas in modern medicine. His presentations will emphasize the need for multidisciplinary collaboration that bridges imaging, research, and clinical data to improve patient outcomes. "The Veith Symposium has long been considered the meeting of reference for vascular medicine," said Jeff Geschwind, MD. "I am especially happy that the AIM symposium was given a dedicated day this year during the Veith Symposium to present the latest data to interventional radiologists and other specialties. It is therefore an honor to share the stage with global experts and contribute to the continued growth of interventional oncology".
About the Veith Symposium
The Veith Symposium addresses a critical need in global healthcare: bridging the gap between medical practice and the latest advances in vascular and endovascular treatment. The conference provides an accredited platform for physicians to earn CME credits while engaging in discussions on new techniques, technologies, and therapeutic strategies. Topics range from pharmacologic and surgical innovations to imaging breakthroughs, ensuring that participants receive the most current, unbiased, and evidence-based education available.
Jointly accredited by the Cleveland Clinic Center for Continuing Education, the symposium awards up to 45.75 AMA PRA Category 1 Credits Trademark , affirming its importance as one of the most credible continuing education opportunities for vascular and interventional specialists. Each year, the Veith Symposiumt fosters dialogue between experts, challenges established conventions, and promotes clinical excellence through over a thousand presentations, panel discussions, and video case studies.
About Dr. Jeff Geschwind
Dr. Jeff Geschwind currently serves as the Medical Director for Oncology, Image-Guided Therapy, and Imaging Core Lab at NAMSA, one of the largest clinical research organizations in the United States. He is also a Medical Advisor to HistoSonics, a company developing non-invasive image-guided therapy for cancer, and a consultant for Cage Pharma-a firm he founded in 2009 that develops cancer drugs targeting tumor metabolism. Additionally, Dr. Geschwind acts as a scientific consultant for Philips Healthcare, advising on oncology and image-guided technologies.
Dr. Geschwind's distinguished academic background began at the University of Pennsylvania and Boston University School of Medicine, followed by residency training at the University of California, San Francisco as an NIH Resident-Scholar.
He later completed his fellowship training in Vascular and Interventional Radiology at Johns Hopkins University School of Medicine, and remained on faculty after completing his training, eventually becoming Professor of Radiology, Surgery, and Oncology and Director of the Division of Vascular and Interventional Radiology.
Over his career, Dr. Geschwind has published nearly 300 peer-reviewed scientific manuscripts, authored the first textbook on Interventional Oncology, and co-edited Abram's Angiography, a leading reference in interventional radiology. His research in tumor metabolism and targeted liver cancer therapies has earned multiple NIH grants, philanthropic funding, and industry recognition. Notably, his Google Scholar H-index of 86 places him among the most cited radiologists in the world-reflecting the lasting impact of his scientific work.
After nearly two decades at Johns Hopkins, Dr. Geschwind was recruited to Yale School of Medicine as Chairman of Radiology and Biomedical Imaging and Radiologist-in-Chief at Yale-New Haven Hospital. There, he established a new laboratory dedicated to liver cancer and interventional oncology, supported by major NIH funding. His leadership has helped advance minimally invasive cancer treatment, inspiring a new generation of physicians and researchers committed to medical innovation.
Advancing the Future of Image-Guided Oncology
Dr. Geschwind's session at the AIM at Veith program will underscore the importance of integrating cancer biology, imaging science, and clinical outcomes into a unified framework for patient-centered care. His contributions not only redefine how patients with liver cancer are treated but also reinforce the vital role of interventional radiology in the broader medical landscape.
The Veith Symposium 2025 promises to be a milestone event for the medical community, offering new insights, interactive learning opportunities, and international collaboration.
For more information on the event, visit www.veithsymposium.org [http://www.veithsymposium.org/].
To learn more about Dr. Jeff Geschwind's research, publications, and professional achievements, visit https://jeffgeschwind.com [https://jeffgeschwind.com/].
Media Contact:
Press Office - Dr. Jeff Geschwind
Website: https://jeffgeschwind.com [https://jeffgeschwind.com/]
Media Contact
Company Name: Veith Symposium
Contact Person: Jeff Geschwind
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=dr-jeff-geschwind-to-present-at-the-prestigious-veith-symposium-2025-in-new-york-city]
Country: United States
Website: https://jeffgeschwind.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Dr. Jeff Geschwind to Present at the Prestigious Veith Symposium 2025 in New York City here
News-ID: 4262629 • Views: …
More Releases from ABNewswire
Time.so Reports 300% Growth in Business Users
Time.so reports 300% growth in business users as global teams rely on its fast world clock, city times, time zones, and weather for planning.
Jan 31, 2026 - Time.so today announced a 300% increase in business users, reflecting rising demand for dependable time data across distributed teams, global customer support, and cross border operations.
The surge follows a clear shift in how companies schedule work. Meetings span continents. Deadlines move with daylight…
Shaun Savvy Helps Tuckaway Farm in Bentonville, Arkansas Sell Out Two CSA Season …
Buffalo-based SEO consultant Shaun Savvy partnered with Tuckaway Farm in Bentonville, Arkansas to help the farm sell out two consecutive CSA seasons, generating over $80,000 in revenue while spending less than $1,000 on paid advertising through a strategic blend of local SEO, high-intent content, and targeted social media campaigns.
Shaun Savvy, a Buffalo-based SEO and digital marketing consultant, announced a successful local marketing case study showcasing how Tuckaway Farm sold out…
Desert-Proven Skincare: How Corrective Skin LLC's Three-Decade Formula Testing C …
Corrective Skin LLC leverages the extreme conditions of the Utah desert as a rigorous testing environment for their professional-grade skincare line. With 30 years of formulation refinement in one of the country's harshest climates, the female-founded company offers growth factor treatments and advanced skincare that deliver results where other products fail.
The Utah desert presents one of the most demanding environments for skin health in North America, making it an ideal…
From College Basketball Courts to Dog Parks: Athlete Develops Weighted Training …
A former college basketball player who relied on weighted vest training for peak athletic performance has channeled that expertise into Canine Weight Set, a specialized fitness system for dogs. The innovative product line applies proven human sports training principles to canine exercise, offering dog owners a safe method to enhance their pets' strength, endurance, and overall health.
The inspiration for breakthrough products often comes from unexpected moments when personal experience intersects…
More Releases for Geschwind
The Right Equipment for Supreme Security
Leading online retailer of video and home security systems announces license plate cameras for perfect readability.
Melville, NY, February 22, 2011 -- SpyTown, a premier online retailer for all security needs and loss prevention provide high quality video security systems and cameras to ensure supreme safety in any home or business. When in need to catch license plate information, SpyTown carries specially designed cameras to allow readability of the numbers and…
